IBDEI0DA ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17750,2)
 ;;=^295221
 ;;^UTILITY(U,$J,358.3,17751,0)
 ;;=V10.46^^110^990^66
 ;;^UTILITY(U,$J,358.3,17751,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17751,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,17751,1,5,0)
 ;;=5^H/O Prostate Cancer
 ;;^UTILITY(U,$J,358.3,17751,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,17752,0)
 ;;=V10.06^^110^990^67
 ;;^UTILITY(U,$J,358.3,17752,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17752,1,4,0)
 ;;=4^V10.06
 ;;^UTILITY(U,$J,358.3,17752,1,5,0)
 ;;=5^H/O Rectal/Anal Cancer
 ;;^UTILITY(U,$J,358.3,17752,2)
 ;;=^295208
 ;;^UTILITY(U,$J,358.3,17753,0)
 ;;=V10.52^^110^990^68
 ;;^UTILITY(U,$J,358.3,17753,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17753,1,4,0)
 ;;=4^V10.52
 ;;^UTILITY(U,$J,358.3,17753,1,5,0)
 ;;=5^H/O Renal Cancer
 ;;^UTILITY(U,$J,358.3,17753,2)
 ;;=H/o Renal Cancer^295229
 ;;^UTILITY(U,$J,358.3,17754,0)
 ;;=V10.04^^110^990^70
 ;;^UTILITY(U,$J,358.3,17754,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17754,1,4,0)
 ;;=4^V10.04
 ;;^UTILITY(U,$J,358.3,17754,1,5,0)
 ;;=5^H/O Stomach Cancer
 ;;^UTILITY(U,$J,358.3,17754,2)
 ;;=^295206
 ;;^UTILITY(U,$J,358.3,17755,0)
 ;;=V10.47^^110^990^71
 ;;^UTILITY(U,$J,358.3,17755,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17755,1,4,0)
 ;;=4^V10.47
 ;;^UTILITY(U,$J,358.3,17755,1,5,0)
 ;;=5^H/O Testicular Cancer
 ;;^UTILITY(U,$J,358.3,17755,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,17756,0)
 ;;=V10.83^^110^990^69
 ;;^UTILITY(U,$J,358.3,17756,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17756,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,17756,1,5,0)
 ;;=5^H/O Skin Cancer
 ;;^UTILITY(U,$J,358.3,17756,2)
 ;;=H/O Skin Cancer^295241
 ;;^UTILITY(U,$J,358.3,17757,0)
 ;;=285.22^^110^990^9
 ;;^UTILITY(U,$J,358.3,17757,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17757,1,4,0)
 ;;=4^285.22
 ;;^UTILITY(U,$J,358.3,17757,1,5,0)
 ;;=5^Anemia In Cancer
 ;;^UTILITY(U,$J,358.3,17757,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,17758,0)
 ;;=285.21^^110^990^10
 ;;^UTILITY(U,$J,358.3,17758,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17758,1,4,0)
 ;;=4^285.21
 ;;^UTILITY(U,$J,358.3,17758,1,5,0)
 ;;=5^Anemia In Renal Dis
 ;;^UTILITY(U,$J,358.3,17758,2)
 ;;=^321977
 ;;^UTILITY(U,$J,358.3,17759,0)
 ;;=285.29^^110^990^11
 ;;^UTILITY(U,$J,358.3,17759,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17759,1,4,0)
 ;;=4^285.29
 ;;^UTILITY(U,$J,358.3,17759,1,5,0)
 ;;=5^Anemia Of Chronic Dis
 ;;^UTILITY(U,$J,358.3,17759,2)
 ;;=^321979
 ;;^UTILITY(U,$J,358.3,17760,0)
 ;;=284.9^^110^990^13
 ;;^UTILITY(U,$J,358.3,17760,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17760,1,4,0)
 ;;=4^284.9
 ;;^UTILITY(U,$J,358.3,17760,1,5,0)
 ;;=5^Aplastic Anemia Nos
 ;;^UTILITY(U,$J,358.3,17760,2)
 ;;=^7020
 ;;^UTILITY(U,$J,358.3,17761,0)
 ;;=282.61^^110^990^75
 ;;^UTILITY(U,$J,358.3,17761,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17761,1,4,0)
 ;;=4^282.61
 ;;^UTILITY(U,$J,358.3,17761,1,5,0)
 ;;=5^Hemoglobin S Disease
 ;;^UTILITY(U,$J,358.3,17761,2)
 ;;=^267981
 ;;^UTILITY(U,$J,358.3,17762,0)
 ;;=282.7^^110^990^74
 ;;^UTILITY(U,$J,358.3,17762,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17762,1,4,0)
 ;;=4^282.7
 ;;^UTILITY(U,$J,358.3,17762,1,5,0)
 ;;=5^Hemoglobin C Disease
 ;;^UTILITY(U,$J,358.3,17762,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,17763,0)
 ;;=283.9^^110^990^77
 ;;^UTILITY(U,$J,358.3,17763,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17763,1,4,0)
 ;;=4^283.9
 ;;^UTILITY(U,$J,358.3,17763,1,5,0)
 ;;=5^Hemolytic Anemia , Acquired
 ;;^UTILITY(U,$J,358.3,17763,2)
 ;;=^7071
 ;;^UTILITY(U,$J,358.3,17764,0)
 ;;=283.0^^110^990^78
 ;;^UTILITY(U,$J,358.3,17764,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17764,1,4,0)
 ;;=4^283.0
 ;;^UTILITY(U,$J,358.3,17764,1,5,0)
 ;;=5^Hemolytic Anemia, Autoimmune
 ;;^UTILITY(U,$J,358.3,17764,2)
 ;;=^7079
 ;;^UTILITY(U,$J,358.3,17765,0)
 ;;=282.9^^110^990^76
 ;;^UTILITY(U,$J,358.3,17765,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17765,1,4,0)
 ;;=4^282.9
 ;;^UTILITY(U,$J,358.3,17765,1,5,0)
 ;;=5^Hemolytic Anem, Heredit
 ;;^UTILITY(U,$J,358.3,17765,2)
 ;;=^56578
 ;;^UTILITY(U,$J,358.3,17766,0)
 ;;=283.19^^110^990^79
 ;;^UTILITY(U,$J,358.3,17766,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17766,1,4,0)
 ;;=4^283.19
 ;;^UTILITY(U,$J,358.3,17766,1,5,0)
 ;;=5^Hemolytic Anemia, Microang
 ;;^UTILITY(U,$J,358.3,17766,2)
 ;;=^293664
 ;;^UTILITY(U,$J,358.3,17767,0)
 ;;=280.9^^110^990^83
 ;;^UTILITY(U,$J,358.3,17767,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17767,1,4,0)
 ;;=4^280.9
 ;;^UTILITY(U,$J,358.3,17767,1,5,0)
 ;;=5^Iron Defic Anemia(Unspecified)
 ;;^UTILITY(U,$J,358.3,17767,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,17768,0)
 ;;=285.1^^110^990^81
 ;;^UTILITY(U,$J,358.3,17768,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17768,1,4,0)
 ;;=4^285.1
 ;;^UTILITY(U,$J,358.3,17768,1,5,0)
 ;;=5^Iron Defic Anemia d/t Acute Blood Loss
 ;;^UTILITY(U,$J,358.3,17768,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,17769,0)
 ;;=280.0^^110^990^82
 ;;^UTILITY(U,$J,358.3,17769,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17769,1,4,0)
 ;;=4^280.0
 ;;^UTILITY(U,$J,358.3,17769,1,5,0)
 ;;=5^Iron Defic Anemia d/t Chr Blood Loss
 ;;^UTILITY(U,$J,358.3,17769,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,17770,0)
 ;;=281.9^^110^990^101
 ;;^UTILITY(U,$J,358.3,17770,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17770,1,4,0)
 ;;=4^281.9
 ;;^UTILITY(U,$J,358.3,17770,1,5,0)
 ;;=5^Nutritional Anemia
 ;;^UTILITY(U,$J,358.3,17770,2)
 ;;=^123801
 ;;^UTILITY(U,$J,358.3,17771,0)
 ;;=281.0^^110^990^121
 ;;^UTILITY(U,$J,358.3,17771,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17771,1,4,0)
 ;;=4^281.0
 ;;^UTILITY(U,$J,358.3,17771,1,5,0)
 ;;=5^Vit B12 Deficiency (Pernicious Anemia)
 ;;^UTILITY(U,$J,358.3,17771,2)
 ;;=^7161
 ;;^UTILITY(U,$J,358.3,17772,0)
 ;;=282.60^^110^990^108
 ;;^UTILITY(U,$J,358.3,17772,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17772,1,4,0)
 ;;=4^282.60
 ;;^UTILITY(U,$J,358.3,17772,1,5,0)
 ;;=5^Sickle-Cell Anemia
 ;;^UTILITY(U,$J,358.3,17772,2)
 ;;=^7188
 ;;^UTILITY(U,$J,358.3,17773,0)
 ;;=282.62^^110^990^109
 ;;^UTILITY(U,$J,358.3,17773,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17773,1,4,0)
 ;;=4^282.62
 ;;^UTILITY(U,$J,358.3,17773,1,5,0)
 ;;=5^Sickle-Cell With Crisis
 ;;^UTILITY(U,$J,358.3,17773,2)
 ;;=^267982
 ;;^UTILITY(U,$J,358.3,17774,0)
 ;;=281.1^^110^990^122
 ;;^UTILITY(U,$J,358.3,17774,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17774,1,4,0)
 ;;=4^281.1
 ;;^UTILITY(U,$J,358.3,17774,1,5,0)
 ;;=5^Vit B12 Deficiency(Dietary)
 ;;^UTILITY(U,$J,358.3,17774,2)
 ;;=^267974
 ;;^UTILITY(U,$J,358.3,17775,0)
 ;;=286.7^^110^990^51
 ;;^UTILITY(U,$J,358.3,17775,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17775,1,4,0)
 ;;=4^286.7
 ;;^UTILITY(U,$J,358.3,17775,1,5,0)
 ;;=5^Coagulation Defect(Any),Acquired
 ;;^UTILITY(U,$J,358.3,17775,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,17776,0)
 ;;=289.9^^110^990^118
 ;;^UTILITY(U,$J,358.3,17776,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17776,1,4,0)
 ;;=4^289.9
 ;;^UTILITY(U,$J,358.3,17776,1,5,0)
 ;;=5^Thrombocytosis, Essential
 ;;^UTILITY(U,$J,358.3,17776,2)
 ;;=^55344
 ;;^UTILITY(U,$J,358.3,17777,0)
 ;;=451.9^^110^990^119
 ;;^UTILITY(U,$J,358.3,17777,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17777,1,4,0)
 ;;=4^451.9
 ;;^UTILITY(U,$J,358.3,17777,1,5,0)
 ;;=5^Thrombophlebitis 
 ;;^UTILITY(U,$J,358.3,17777,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,17778,0)
 ;;=446.6^^110^990^120
 ;;^UTILITY(U,$J,358.3,17778,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17778,1,4,0)
 ;;=4^446.6
 ;;^UTILITY(U,$J,358.3,17778,1,5,0)
 ;;=5^Thrombotic Thrombocytopenic Purpura(TTP)
 ;;^UTILITY(U,$J,358.3,17778,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,17779,0)
 ;;=286.4^^110^990^123
 ;;^UTILITY(U,$J,358.3,17779,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17779,1,4,0)
 ;;=4^286.4
 ;;^UTILITY(U,$J,358.3,17779,1,5,0)
 ;;=5^Von Willebrand's Disease
 ;;^UTILITY(U,$J,358.3,17779,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,17780,0)
 ;;=204.00^^110^990^2
 ;;^UTILITY(U,$J,358.3,17780,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17780,1,4,0)
 ;;=4^204.00
 ;;^UTILITY(U,$J,358.3,17780,1,5,0)
 ;;=5^ALL w/o Remission
 ;;^UTILITY(U,$J,358.3,17780,2)
 ;;=^267521
 ;;^UTILITY(U,$J,358.3,17781,0)
 ;;=204.01^^110^990^1
 ;;^UTILITY(U,$J,358.3,17781,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17781,1,4,0)
 ;;=4^204.01
 ;;^UTILITY(U,$J,358.3,17781,1,5,0)
 ;;=5^ALL in Remission
 ;;^UTILITY(U,$J,358.3,17781,2)
 ;;=^267522
 ;;^UTILITY(U,$J,358.3,17782,0)
 ;;=204.10^^110^990^26
 ;;^UTILITY(U,$J,358.3,17782,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17782,1,4,0)
 ;;=4^204.10
 ;;^UTILITY(U,$J,358.3,17782,1,5,0)
 ;;=5^CLL w/o Remission
 ;;^UTILITY(U,$J,358.3,17782,2)
 ;;=^267523
 ;;^UTILITY(U,$J,358.3,17783,0)
 ;;=204.11^^110^990^24
 ;;^UTILITY(U,$J,358.3,17783,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17783,1,4,0)
 ;;=4^204.11
 ;;^UTILITY(U,$J,358.3,17783,1,5,0)
 ;;=5^CLL in Remission
 ;;^UTILITY(U,$J,358.3,17783,2)
 ;;=^267524
 ;;^UTILITY(U,$J,358.3,17784,0)
 ;;=202.41^^110^990^73
 ;;^UTILITY(U,$J,358.3,17784,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17784,1,4,0)
 ;;=4^202.41
 ;;^UTILITY(U,$J,358.3,17784,1,5,0)
 ;;=5^Hairy Cell Leukemia,Unspec Site
 ;;^UTILITY(U,$J,358.3,17784,2)
 ;;=^267472
 ;;^UTILITY(U,$J,358.3,17785,0)
 ;;=201.90^^110^990^80
 ;;^UTILITY(U,$J,358.3,17785,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17785,1,4,0)
 ;;=4^201.90
 ;;^UTILITY(U,$J,358.3,17785,1,5,0)
 ;;=5^Hodgkin's Lymphoma,Unspec Type & Site
 ;;^UTILITY(U,$J,358.3,17785,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,17786,0)
 ;;=785.6^^110^990^86
 ;;^UTILITY(U,$J,358.3,17786,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17786,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,17786,1,5,0)
 ;;=5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,17786,2)
 ;;=^72368
 ;;^UTILITY(U,$J,358.3,17787,0)
 ;;=200.20^^110^990^89
 ;;^UTILITY(U,$J,358.3,17787,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17787,1,4,0)
 ;;=4^200.20
 ;;^UTILITY(U,$J,358.3,17787,1,5,0)
 ;;=5^Lymphoma,Burkett's,Unspecified Sites
